National Comprehensive Cancer Network



About NCCN

Breast Cancer Panel - Disclosures as of 1/13/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Benjamin O. Anderson, MD

None

None

None

None

None

2/24/2015

Sarah L. Blair, MD

None

None

None

None

None

1/21/2015

Harold J. Burstein, MD, PhD

None

None

None

None

None

9/16/2014

Amy Cyr, MD

None

None

None

None

None

2/24/2015

Anthony D. Elias, MD

None

Genentech, Inc.

None

None

None

1/29/2015

William B. Farrar, MD

None

None

None

None

None

12/10/2014

Andres Forero, MD

Abbott Laboratories;
Biogen Idec;
Celgene Corporation;
Daiichi- Sankyo Co.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

None

6/9/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Sharon Hermes Giordano, MD, MPH

None

None

None

None

None

2/13/2015

Lori J. Goldstein, MD

None

Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation

Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Nanostring;
Syntax

None

None

2/12/2015

William J. Gradishar, MD

None

Bayer HealthCare;
Eisai Inc.;
Genentech, Inc.;
Genomic Health, Inc.;
Myriad Genetic Laboratories, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

None

11/21/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

9/16/2014

Daniel F. Hayes, MD

Janssen Pharmaceuticals

Inbiomotion;
Oncimmune

None

None

None

5/7/2014

Clifford A. Hudis, MD

Alliance;
I-SPY2

None

None

ASCO;
Breast Cancer Research Foundation

None

1/24/2015

Steven Jay Isakoff, MD, PhD

None

Myriad Genetic Laboratories, Inc.

None

None

None

7/20/2014

Rashmi Kumar, PhD

None

None

None

None

None

11/7/2014

Britt-Marie E. Ljung, MD

National Cancer Institute;
National Cancer Institute

None

None

None

None

1/31/2013

P. Kelly Marcom, MD

Abbott Laboratories;
Veridex, LLC

Novartis Pharmaceuticals Corporation;
Nanostring

None

None

None

2/6/2015

Ingrid A. Mayer, MD

None

None

None

None

None

9/16/2014

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Beryl McCormick, MD

None

None

None

None

None

2/16/2015

Robert S. Miller, MD

None

None

None

None

None

9/24/2014

Mark Pegram, MD

None

None

None

None

None

6/9/2014

Lori J. Pierce, MD

None

Genomic Health, Inc.

None

UpToDate

None

2/13/2015

Elizabeth C. Reed, MD

Agendia BV;
Novartis Pharmaceuticals Corporation

UnitedHealthcare

None

None

None

8/20/2013

Kilian E. Salerno, MD

None

None

None

None

None

9/16/2014

Lee S. Schwartzberg, MD, FACP

None

Amgen Inc.;
Eisai Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

None

2/19/2015

Dorothy Shead, MS

None

None

None

None

None

2/18/2015

Mary Lou Smith, JD, MBA

Genentech, Inc.

None

None

Gateway for Cancer Research Foundation;
National Accreditation Program for Breast Centers

None

1/3/2015

Hatem Soliman, MD

None

Agendia BV;
Celgene Corporation;
NanoString;
Veridex, LLC

None

None

None

2/13/2015

George Somlo, MD

None

Celgene Corporation;
Genentech, Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Abraxane;
Abraxane;
Abraxane;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.

None

None

None

1/21/2015

Sarika Trikha, PharmD

None

None

None

None

None

11/11/2014

John H. Ward, MD

None

None

None

None

None

12/10/2014

Richard Zellars, MD

None

None

None

None

None

11/5/2013